WHO report, samples result on mysterious deaths of Gambia children still pending: Sources

As per sources, India's drug regulator has written several times to the international body but there has been no response.;

Published On 2022-12-06 12:00 GMT | Update On 2022-12-06 12:01 GMT

New Delhi: The World Health Organization (WHO) has failed to respond to the Government of India's requirement for relevant documents for further investigation into the deaths of 70 children in Gambia and cough syrups made by Sonipat-based Indian company Maiden pharmaceuticals, sources said.

The Committee formed by the Union Ministry of Health & Family Welfare to investigate this matter has so far conducted three meetings and reviewed the matter.

But without the sample results, WHO reply, and lack of evidence, the Committee has put the further investigation on hold and is no longer conducting meetings, sources told ANI.

As per sources, India's drug regulator has written several times to the international body but there has been no response. ANI team tried to contact the Drugs Controller General of India (DCGI) regarding more information on this matter but there was no response.

Earlier, citing the representative of the country's Medicines Control Agency, Gambian media reports said it has not yet been confirmed that toxic cough syrup was the cause of the deaths of 70 children from acute kidney injury.

Tijan Jallow, the regulatory officer of Gambia's Medicines Control Agency (MCA) told a newspaper that, "95 percent of kids that died from the acute Kidney injuries are from flooded areas."

He said this during an organised press conference.

Last month, WHO said the clinical investigations in The Gambia are still ongoing.

"...But the fact is, from the WHO perspective, the investigation into the causal relationship between the use of medication, contaminated, substandard medication and deaths, this investigation and any further information has to be provided by the Ministry of Health in Gambia," said Dr Mariangela Simao, during a virtual press conference.

"We're working very closely with them," she added.

Article Source : ANI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

WHO report, samples result on mysterious deaths of Gambia children still pending: Sources

As per sources, India's drug regulator has written several times to the international body but there has been no response.;

Similar News

Madras HC Flags Licensing Gap, Says Ayurvedic Imports Must Meet Indian Drug Standards

DoP again extends timeline for submitting applications under PLI Scheme for pharma sector

Alembic Pharma ropes in G Krishnan as CFO

Harsh V Trehan named CHRO, Executive Vice President at GSK India

Sun Pharma Advanced Research Company incorporates wholly owned subsidiary Genokine Biotech

42 dead, 8 still missing in Sigachi pharma plant explosion

Akums Drugs and Pharma: Jitendra Mishra steps down as Senior Vice President - IT

Biocon Biologics gets marketing nods in UK for Vevzuo, Evfraxy